Integra Lifesciences News

Integra LifeSciences To Spotlight CereLink Intracranial Pressure Monitoring System At The American Association Of Neurological Surgeons Annual Scientific Meeting

Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, is pleased to announce that following a successful Q1 2024 U.S. relaunch of its CereLink ICP Monit

BenzingaApr 30 17:27 ET

Buy Rating for Integra Lifesciences Amid Favorable Medicare Policy Changes

TipRanksApr 26 05:20 ET

Jefferies Sticks to Their Buy Rating for Integra Lifesciences (IART)

TipRanksApr 22 09:25 ET

Express News | Integra LifeSciences Shares Are Trading Lower. The Company Announced It Will Reschedule Its Q1 Financial Results Conference Call

Moomoo 24/7Apr 19 15:56 ET

Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024

PRINCETON, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that it has rescheduled the release of the

GlobeNewswireApr 18 17:24 ET

Earnings Preview: Integra LifeSciences (IART) Q1 Earnings Expected to Decline

Yahoo FinanceApr 17 10:01 ET

Express News | Integra Lifesciences Holdings Corp : Truist Securities Cuts Target Price to $37 From $41

Moomoo 24/7Apr 15 04:25 ET

Here's Why Investors Should Retain Integra (IART) Stock Now

Yahoo FinanceApr 9 08:41 ET

Top Buy-rated Stocks and Sell-rated Stocks Within Health Care - Citi

Seeking AlphaApr 4 11:12 ET

Integra LifeSciences Raised to Neutral From Sell by Citigroup

Integra LifeSciences Raised to Neutral From Sell by Citigroup

Dow JonesApr 3 11:41 ET

Citigroup Upgrades Integra LifeSciences to Neutral From Sell, Price Target Is $38

Integra LifeSciences Holdings (IART) has an average rating of hold and price targets ranging from $37 to $57, according to analysts polled by Capital IQ.

MT NewswiresApr 3 08:40 ET

Integra LifeSciences Completes Acquisition of J&J's Acclarent

MassDeviceApr 2 09:09 ET

Integra LifeSciences Completes The Acquisition Of Acclarent, Inc. >IART

Integra LifeSciences Completes The Acquisition Of Acclarent, Inc. >IART

Dow JonesApr 1 16:15 ET

Press Release: Integra LifeSciences Completes the Acquisition of Acclarent, Inc.

Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced it has successfully completed its acquisition of Acclarent, Inc., a pioneer in ear, nose and throat (ENT) surgical interventions.

Dow JonesApr 1 16:15 ET

Integra LifeSciences Holdings' (NASDAQ:IART) Earnings Have Declined Over Three Years, Contributing to Shareholders 48% Loss

Yahoo FinanceMar 31 10:58 ET

Why Is Integra (IART) Down 4% Since Last Earnings Report?

Yahoo FinanceMar 29 11:30 ET

Are Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

It is hard to get excited after looking at Integra LifeSciences Holdings' (NASDAQ:IART) recent performance, when its stock has declined 21% over the past month. However, stock prices are usually dri

Simply Wall StMar 28 08:58 ET

11 Oversold Healthcare Stocks To Buy Right Now

Yahoo FinanceMar 13 08:17 ET

Some May Be Optimistic About Integra LifeSciences Holdings' (NASDAQ:IART) Earnings

Integra LifeSciences Holdings Corporation's (NASDAQ:IART) earnings announcement last week didn't impress shareholders. While the headline numbers were soft, we believe that investors might be missing

Simply Wall StMar 12 14:35 ET

Integra LifeSciences (IART) Introduces MicroMatrix Flex

Yahoo FinanceMar 12 12:04 ET